Atopic Dermatitis (AD) - Market Insights, Epidemiology and Market Forecast - 2025

Tuesday, October 24, 2017 Environmental Health
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 23, 2017 /PRNewswire/ -- DelveInsight's 'Atopic Dermatitis - Market Insights, Epidemiology and Market Forecast-2025' report provides an overview of epidemiology and market trend of Atopic Dermatitis for the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Download the full report: Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Atopic Dermatitis from 2017 to 2025 segmented by seven major
markets. In addition, the report also includes the forecasted epidemiology of Atopic Dermatitis till 2025. The Report also covers market drivers, market barriers and unmet medical need. Our report provides the subtype specific prevalent population i.e., Mild Atopic Dermatitis, Moderate Atopic Dermatitis and Severe Atopic Dermatitis. According to DelveInsight, the prevalent population of Atopic Dermatitis is expected to reach up to XXX cases by the end of 2025 at a CAGR of XX% from 2015-2025. High prevalent cases were observed in United States as compared to EU5 and Japan. Market is driven by various approved drugs for Atopic Dermatitis such as Elidel (Novartis), Protopic (Fujisawa Healthcare) and Desonate (Bayer Healthcare). There has been a positive impact on the market with the approval of Eucrisa (Pfizer) and Dupilumab (Regeneron Pharmaceuticals/Sanofi) in 2016 and 2017 respectively. United States contributes the major share of Atopic Dermatitis market as compared to EU5 countries and Japan. The therapeutic market of Atopic Dermatitis in 7MM is expected to reach USD XXX Million in 2025 at the CAGR of XX% from 2015-2025. Key Coverage and Benefits: • The report will help in developing business strategies by understanding the trends shaping and driving the Atopic Dermatitis market. • The Report provides detailed historical and forecasted epidemiological data of Atopic Dermatitis in the 7MM i.e., United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025. • Organize sales and marketing efforts by identifying the best opportunities for Atopic Dermatitis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan. • To understand the future market competition in the Atopic Dermatitis market and insightful review of the key market drivers and barriers. • To understand the regulatory scenario in major markets. • The Report covers the detailed historical and forecasted Atopic Dermatitis market covering the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store